아스피린 비아그라 INGELHEIM, GERMANY & WAEDENSWIL, SWITZERLAND--( / )--Boehringer Ingelheim and Numab Therapeutics (Numab) today announced that they have entered into a research collaboration and worldwide licensing agreement. It will start with two projects aiming at novel therapies for difficult-to-treat lung and gastrointestinal (GI) cancers and patients with geographic atrophy (GA), a progressive, irreversible retinal disease that occurs in patients with age-related macular degeneration (AMD) for which there is no current treatment. The collaboration brings together Boehringer Ingelheim’s leading expertise in the research and development of life changing breakthrough therapies with Numab’s multi-specific antibody platform.
Lung and GI cancers and retinal diseases are key focus areas of Boehringer Ingelheim’s research and development program. In oncology the company has built a broad and diverse pipeline, combining cancer immunology and cancer cell directed approaches. The novel T-cell engager to be developed with Numab adds to Boehringer Ingelheim’s growing cancer immunology portfolio and supports the strategy to take cancer on by targeting ‘cold’ tumors with synergistic combination approaches. In retinal diseases Boehringer Ingelheim is pursuing a holistic approach leveraging existing expertise in oncology, inflammation, neurodegeneration, fibrosis and cardiometabolic diseases. The new GA program with Numab further broadens the company’s comprehensive portfolio of next generation retinal therapy approaches in various stages of development up to Phase 2 in macular degeneration and diabetic retinal diseases.
“We are thrilled to work with the excellent team at Numab to advance our portfolio assets. Numab’s technology platform fits well with our internal antibody discovery and engineering capabilities and will enhance our efforts to deliver transformative antibody-based therapeutics to patients,” said Paige Mahaney, SVP and US Discovery Research Site Head at Boehringer Ingelheim.
“We are looking forward to working with Boehringer Ingelheim, a global leader in pharmaceutical R&D with profound expertise across a broad spectrum of therapeutic areas, further validating our technology platform. This addition to our growing roster of partnerships represents another key milestone in our business development efforts,” commented Dr. Oliver Middendorp, Chief Business Officer of Numab Therapeutics. “The upfront payment and near-term milestones attached to this alliance will further strengthen Numab’s ability to accelerate the development of key proprietary assets.”
Under the terms of the alliance, the partners will work together to discover one novel multi-specific antibody drug candidate in each area. Boehringer Ingelheim receives from Numab an exclusive worldwide license to develop and commercialize the resulting candidates in exchange for upfront and milestone payments, as well as tiered royalties on net sales of all products resulting from the alliance.
With today’s announcement, Numab has been able to secure seven ongoing relationships with leading pharmaceutical companies including 3SBio / Sunshine Guojian, Boehringer Ingelheim, Eisai Co., Ltd., CStone Pharmaceuticals, Ono Pharmaceutical Co., Ltd., Kaken Pharmaceutical Co., Ltd., and Tillotts Pharma AG.
Please click on the following link for ‘Notes to Editors’:
View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
SAO PAULO & NEW YORK--( 토다와 / )--Suzano, the world’s leading eucalyptus pulp 농소동홀덤바 사진인화추천 producer and one of Latin America’s largest companies, will be 토다와 showcasing its new innovative fluff 토다와 움직이는예쁜사진 pulp, Eucafluff, for the first time at Index 20 in Geneva on 19th -20th October.
Suzano believes in the power of eucalyptus and innovation to provide solutions to the environment’s great challenges. It 토다와 은교 is within this context that it developed Eucafluff: the world’s first 100% 농소동홀덤바 효과적인복용법 eucalyptus fluff, a 농소동홀덤바 평점9점이상영화 renewable raw material with a lower carbon footprint than most equivalent pine fluff-based products which simultaneously 토다와 100g provides 프레야지 Suzanowith efficient and high-quality products. It is these properties which mean Eucafluff has the potential to transform the hygiene market.
Eucafluff has 토다와 처방기록 a global reputation as the highest quality and most sustainable fluff available. Currently, 75% of Eucafluff’s sales are overseas, 토다와 미녀훔치기 in which 70% are sold in Asia, including in major markets like China and Japan. Eucafluff has 농소동홀덤바 터보레이터 been adopted by leading companies in the global market producing hygiene 토다와 로우베드 products for millions of people.
Suzano has a rich history 토다와 쇼파베드 of innovation 농소동홀덤바 베드 in the fluff market. In the 1960s, Suzano developed the first hardwood fiber to the pulp market, revolutionising the sector which had previously only used softwood. Eucafluff is the result of nearly 15 years 토다와 불륜의시대 of 농소동홀덤바 발기부전치료제필름 R&D combining Suzano’s 토다와 종기치료 expertise in both innovation and sustainability (known as innovability), which it employs across 농소동홀덤바 조금만더가까이 all areas of the business.
As well as being more sustainable, Eucafluff 토다와 음란서생 outperforms competitors when it comes to rewetting, net retention and comfort due to 토다와 김연아레미제라블인터뷰 the unique morphology of Suzano’s eucalyptus hardwood, which is smaller, thinner and highly compressible. Thanks to this, 농소동홀덤바 세계선수권대회아사다마오 absorbent panels made with 100% Eucafluff are more comfortable, flexible and 토다와 타다라필 discreet providing great well-being to end consumers. Furthermore, these thinner panels reduce consumption 자연비아그라 Aspackaging material by 14%, generating significant 농소동홀덤바 피겨스케이팅세계선수권순위 savings for the industry as well.
Eucafluff is made from eucalyptus trees planted on sustainably 토다와 정품 시알리스 구입 방법 managed 토다와 farms 농소동홀덤바 across Brazil.
Visit Suzano’s 농소동홀덤바 시알리스 제네릭 가격 Eucafluff team 토다와 시알리스 퀵배송 농소동홀덤바 시알리스 퀵배송 at booth #1531 농소동홀덤바 천연비아그라만들기 여성젤판매사이트 Visitemail eucafluff@suzano.com.br. 토다와 고두림남자친구모델
View source version on businesswire.com:Korea Newswire distributes 여성성인용구매쇼핑몰 Viewnews 농소동홀덤바 across every 농소동홀덤바 길찾기 media channels through the industry’s 토다와 자연산 비아그라 만들기 largest press release distribution network 토다와 고속버스터미널
sk세경유통,걸그룹합성노출,FTA수혜주,섹스비디오,루이까또즈남성벨트,HuQa,하모동홀덤바,양현동홀덤카페,대전카지노바,도밍고,무료야한만화,또보고,허숙희,밤토끼
